Success Metrics

Clinical Success Rate
90.9%

Based on 20 completed trials

Completion Rate
91%(20/22)
Active Trials
3(9%)
Results Posted
15%(3 trials)
Terminated
2(6%)

Phase Distribution

Ph phase_2
5
16%
Ph phase_4
6
19%
Ph phase_3
7
22%
Ph early_phase_1
1
3%
Ph phase_1
1
3%
Ph not_applicable
11
34%

Phase Distribution

2

Early Stage

5

Mid Stage

13

Late Stage

Phase Distribution31 total trials
Early Phase 1First-in-human
1(3.2%)
Phase 1Safety & dosage
1(3.2%)
Phase 2Efficacy & side effects
5(16.1%)
Phase 3Large-scale testing
7(22.6%)
Phase 4Post-market surveillance
6(19.4%)
N/ANon-phased studies
11(35.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.0%

20 of 23 finished

Non-Completion Rate

13.0%

3 ended early

Currently Active

3

trials recruiting

Total Trials

32

all time

Status Distribution
Active(4)
Completed(20)
Terminated(3)
Other(5)

Detailed Status

Completed20
unknown5
Terminated2
Recruiting2
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
3
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.2%)
Phase 11 (3.2%)
Phase 25 (16.1%)
Phase 37 (22.6%)
Phase 46 (19.4%)
N/A11 (35.5%)

Trials by Status

completed2063%
active_not_recruiting13%
not_yet_recruiting13%
terminated26%
unknown516%
withdrawn13%
recruiting26%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT05562518Phase 4

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

Active Not Recruiting
NCT07420218Phase 4

Menopausal Hormones and Sympathetic Activation

Not Yet Recruiting
NCT06520982Early Phase 1

Early Neurovascular Adaptations in Aging Women

Recruiting
NCT04531943

Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

Completed
NCT05283421Not Applicable

Improving Diagnostics in Cervical Dysplasia

Recruiting
NCT04233892Phase 1

Clinical Study of in Situ Regeneration of Endometrium

Unknown
NCT05302726Not Applicable

Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation

Unknown
NCT00827151Phase 3

Bone Mass Accrual in Adolescent Athletes

Withdrawn
NCT00229450Phase 4

Estrogen and Perimenopausal Depression

Completed
NCT00565916Not Applicable

Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

Terminated
NCT00805207Not Applicable

Sex Steroids, Sleep, and Metabolic Dysfunction in Women

Completed
NCT03269916Not Applicable

Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel Disease

Unknown
NCT00680797Not Applicable

Metabolic Effects of Androgenicity in Aging Men and Women

Completed
NCT03120715Phase 4

Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo Transfer

Unknown
NCT02419729Phase 3

Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy

Completed
NCT01833663Phase 4

Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women

Completed
NCT00000483Not Applicable

Coronary Drug Project Mortality Surveillance

Completed
NCT00000482Phase 3

Coronary Drug Project

Completed
NCT01295892Phase 4

Chronic Effects of Estrogen in Microcirculation

Completed
NCT00029159Phase 3

The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome

Completed

Drug Details

Intervention Type
DRUG
Total Trials
32